4//SEC Filing
PDL BIOPHARMA, INC. 4
Accession 0000882104-14-000083
CIK 0000882104operating
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 8:43 PM ET
Size
8.5 KB
Accession
0000882104-14-000083
Insider Transaction Report
Form 4
Hart Danny J Jr.
Assoc Genl Counsel/Asst Sec
Transactions
- Award
Common stock
2014-09-30+1,611→ 49,377 total
Footnotes (1)
- [F1]The restricted stock will vest, provided that the officer remains employed by the Company and certain performance goals are achieved, based upon the following schedule: 50% on December 12, 2015; 16.66% on December 12, 2016; 16.66% on December 12, 2017; and 16.66% on December 12, 2018.
Issuer
PDL BIOPHARMA, INC.
CIK 0000882104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000882104
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 8:43 PM ET
- Size
- 8.5 KB